BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5%- betamethasone dipropionate 0.05% / minoxidil 5% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5%

Directions for use

e

Sincerus Florida, LLC adverse reactions.

z

Active, inactive

x

NDC 72934-4023-8
BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5%
Solution 60gm

x

BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% 
betamethasone dipropionate 0.05% / minoxidil 5% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4023
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1) MINOXIDIL5 g  in 100 g
BETAMETHASONE DIPROPIONATE (UNII: 826Y60901U) (BETAMETHASONE - UNII:9842X06Q6M) BETAMETHASONE0.05 g  in 100 g
Product Characteristics
Colorwhite (CLEAR SOLUTION) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4023-860 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product05/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4023)

Revised: 4/2019
Document Id: 8747c1ea-6b25-46c8-e053-2995a90a33df
Set id: 8747c1ea-6b24-46c8-e053-2995a90a33df
Version: 1
Effective Time: 20190424
 
Sincerus Florida, LLC